FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Su Metcalfe

Research Profile

Living Beings

Procedures

Chemicals & Drugs

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Su M Metcalfe; Tarek M Fahmy
Targeted nanotherapy for induction of therapeutic immune responses.
Huansheng Dong; Xiao Dong; Tarek M Fahmy; Wenda Gao; Luca Inverardi; Su M Metcalfe; Steve L Morton; David B Adams; Hongjun Wang
Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice.
Su M Metcalfe
Multiple sclerosis: One protein, two healing properties.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Su Metcalfe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Su M Metcalfe; Tarek M Fahmy
Targeted nanotherapy for induction of therapeutic immune responses.
Trends in molecular medicine 2012;18(2):72-80.
2012: Huansheng Dong; Xiao Dong; Tarek M Fahmy; Wenda Gao; Luca Inverardi; Su M Metcalfe; Steve L Morton; David B Adams; Hongjun Wang
Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice.
PloS one 2012;7(12):e50265.
2011: Su M Metcalfe
Multiple sclerosis: One protein, two healing properties.
Nature 2011;477(7364):287-8.
2011: Su M Metcalfe
LIF in the regulation of T-cell fate and as a potential therapeutic.
Genes and immunity 2011;12(3):157-68.
2010: Lorraine H Thompson; RA Whiston; Yerzhan Rakhimov; Cristian Taccioli; Chang-Gong Liu; Carlo Croce; Su M Metcalfe
A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor.
Cell cycle (Georgetown, Tex.) 2010;9(20):4213-21.
2010: Cristina A Szigyarto; Paul Sibbons; Gill Williams; Mathias Uhlen; Su M Metcalfe
The E3 ligase axotrophin/MARCH-7: protein expression profiling of human tissues reveals links to adult stem cells.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2010;58(4):301-8.
2009: Wenda Gao; Lorraine Thompson; Qiang Zhou; Prabhakar Putheti; Tarek M Fahmy; Terry B Strom; Su M Metcalfe
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.
Cell cycle (Georgetown, Tex.) 2009;8(9):1444-50.
2008: Poorni A D S Muthukumarana; Xin X Zheng; Bruce R Rosengard; Terry B Strom; Su M Metcalfe
In primed allo-tolerance, TIM-3-Ig rapidly suppresses TGFbeta, but has no immediate effect on Foxp3.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(6):593-7.
2007: Poorni A De S Muthukumarana; Wook-Jin Chae; Stephen E Maher; Bruce R Rosengard; Alfred L M Bothwell; Su M Metcalfe
Regulatory transplantation tolerance and "stemness": evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcription.
Transplantation 2007;84(1 Suppl):S6-11.
2006: Poorni A De S Muthukumarana; Gary E Lyons; Yuji Miura; Lorraine H Thompson; Tracy Watson; Colin J Green; Sandra Shurey; Allan Hess; Bruce R Rosengard; Su M Metcalfe
Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance.
International immunopharmacology 2006;6(13-14):1993-2001.
2005: Su M Metcalfe
Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2005;360(1461):1687-94.
2005: Su M Metcalfe; Roy Y Calne; Stephen P Cobbold
Introduction: immunoregulation: harnessing T cell biology for therapeutic benefit.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2005;360(1461):1641-3.
2005: Su M Metcalfe; Tracy J Watson; Sandra Shurey; Elizabeth Adams; Colin J Green
Leukemia inhibitory factor is linked to regulatory transplantation tolerance.
Transplantation 2005;79(6):726-30.
2005: Su M Metcalfe; Poorni A De S Muthukumarana; H Lorraine Thompson; melissa haendel; Gary E Lyons
Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance.
FEBS letters 2005;579(3):609-14.
2005: Su M Metcalfe; Poorni A De S Muthukumarana
Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejection.
International immunopharmacology 2005;5(1):33-9.
2001: Joannis Vamvakopoulos; Craig J Taylor; Colin Green; K McNeil; Su M Metcalfe
Genetic modulators of interleukin 1 activity influence the development of chronic rejection in human thoracic allografts.
Transplantation proceedings 2001;33(1-2):1563-4.
2000: SD Moffatt; Su M Metcalfe
Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade.
Transplantation 2000;69(8):1724-6.
2000: SD Moffatt; M Cockman; Su M Metcalfe
STAT 6 up-regulation by FK506 in the presence of interleukin-4.
Transplantation 2000;69(7):1521-3.
1999: SD Moffatt; Vivian Mcalister; Roy Y Calne; Su M Metcalfe
Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies.
Transplantation proceedings 1999;31(7):2754.
1999: SD Moffatt; Su M Metcalfe
FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
Transplantation proceedings 1999;31(7):2740.
1999: SD Moffatt; Vivian Mcalister; Roy Y Calne; Su M Metcalfe
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model.
Transplantation 1999;67(9):1205-8.
1999: ZK Chen; Su M Metcalfe
Thymic-independent peripheral tolerance.
Transplantation proceedings 1999;31(1-2):802-3.
1998: Su M Metcalfe; M Cockman; A J Milner
In vitro transcription and translation of the tumour suppressor protein P53: qualitative and quantitative effects of FK506 and rapamycin.
Transplantation proceedings 1998;30(8):4108-9.
1997: Su M Metcalfe; Shilpy Sharma; J Milner; R E Morris; S Goldman; Michael B Kastan
Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells.
Oncogene 1997;15(14):1635-42.
1997: Richard M Smith; Z K Chen; R Foulkes; Su M Metcalfe; D C Wraith
Prolongation of murine vascularized heart allograft survival by recipient-specific anti-major histocompatibility complex class II antibody.
Transplantation 1997;64(3):525-8.
1996: ZK Chen; Stephen P Cobbold; Herman Waldmann; Su M Metcalfe
Amplification of natural regulatory immune mechanisms for transplantation tolerance.
Transplantation 1996;62(9):1200-6.
1995: K K Tan; Andrew K Trull; J A Uttridge; Su M Metcalfe; C S Heyes; S Facey; D B Evans
Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in kidney transplant recipients.
Clinical pharmacology and therapeutics 1995;57(4):425-33.
1995: C J Watson; H F Davies; Stephen P Cobbold; A Rasmussen; Peppy Rebello; Sathia Thiru; Herman Waldmann; Roy Y Calne; Su M Metcalfe
CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
Transplantation proceedings 1995;27(1):123-4.
1995: S R Calne; Su M Metcalfe
New immunosuppressive reagents to aid the induction of tolerance in organ graft recipients.
Surgical technology international 1995;IV():290-5.
1994: K K Tan; Andrew K Trull; J A Uttridge; Su M Metcalfe; C S Heyes; S Facey; D Evans
Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in renal transplant recipients.
Transplantation proceedings 1994;26(5):2955-6.
1994: Z Chen; S Cobbold; Herman Waldmann; Su M Metcalfe
Combined use of RS61443 with CD4 and CD8 MAbs to generate tolerance to skin xenografts from rat to mouse.
Transplantation proceedings 1994;26(4):2433-4.
1994: H S Davies; Stephen P Cobbold; C J Watson; Su M Metcalfe; Peppy Rebello; Sathia Thiru; R McNair; A Rasmussen; Herman Waldmann; Roy Y Calne
Production, selection, and testing of monoclonal antibodies to canine leukocytes in the dog kidney allograft model.
Transplantation proceedings 1994;26(4):1941-2.
1994: Z Chen; Stephen P Cobbold; Herman Waldmann; Su M Metcalfe
Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
Transplantation proceedings 1994;26(3):1199-200.
1994: Roy Y Calne; C J Watson; I G Brons; H Makisalo; Su M Metcalfe; V Sriwatanawongsa; H S Davies
Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporine.
Transplantation 1994;57(10):1433-5.
1994: S Cobbold; Su M Metcalfe
Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW).
Tissue antigens 1994;43(3):137-54.
1994: C J Watson; Stephen P Cobbold; H S Davies; Peppy Rebello; Sathia Thiru; R McNair; A Rasmussen; Herman Waldmann; Roy Y Calne; Su M Metcalfe
Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
Tissue antigens 1994;43(3):155-62.
1994: C J Watson; Stephen P Cobbold; H F Davies; Peppy Rebello; Herman Waldmann; Roy Y Calne; Su M Metcalfe
CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S322-4.
1993: C J Watson; Stephen P Cobbold; H S Davies; Peppy Rebello; Herman Waldmann; Roy Y Calne; Su M Metcalfe
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
The British journal of surgery 1993;80(11):1389-92.
1993: C J Watson; Su M Metcalfe; D G St John Collier; Roy Y Calne
A comparative study of cyclosporine and its derivative SDZ IMM-125 in canine renal allografts.
Transplantation 1993;56(5):1248-50.
1993: C J Watson; Roger Luddington; D G St John Collier; Roy Y Calne; Su M Metcalfe
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival.
Transplantation 1993;56(4):1047-9.
1993: C J Watson; H S Davies; Su M Metcalfe; Stephen P Cobbold; Peppy Rebello; D S Collier; Herman Waldmann; Roy Y Calne
CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Transplantation proceedings 1993;25(1 Pt 1):804-6.
1993: Z Chen; S Cobbold; Herman Waldmann; Su M Metcalfe
Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
Transplantation proceedings 1993;25(1 Pt 1):790-1.
1992: Frances M Richards; J Milner; Su M Metcalfe
Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin.
Immunology 1992;76(4):642-7.
1992: Z Chen; S Cobbold; Su M Metcalfe; Herman Waldmann
Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
European journal of immunology 1992;22(3):805-10.
1991: Su M Metcalfe; C J Watson; D G Collier; M DaCosta; Peter J Friend; S G Pollard; Roger Luddington; Roy Y Calne
Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
Transplantation proceedings 1991;23(4):2219-20.
1991: Su M Metcalfe; J Milner
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A.
Transplantation 1991;51(6):1318-20.
1990: Su M Metcalfe; J Milner
Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation.
Immunology letters 1990;26(2):177-82.
1990: S G Pollard; M A Forbes; Su M Metcalfe; E H Cooper; Roy Y Calne
Hyaluronic acid in the assessment of liver graft function.
Transplantation proceedings 1990;22(5):2301-2.
1990: M Da Costa; Su M Metcalfe; Roy Y Calne
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170.
Transplantation proceedings 1990;22(4):1945-6.
1990: Su M Metcalfe; J Milner; Frances M Richards
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells.
Transplantation proceedings 1990;22(4):1547-8.
1990: Su M Metcalfe; Frances M Richards
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells.
Transplantation 1990;49(4):798-802.